Skip to content

Clinical trials

Completed Phase 2/3 trials in Indonesia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Status: Completed Country / region: Indonesia Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20071
20111
20143
20151
20161
20171
20183
20193
20202
20215
20224
20234
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
PT Bio Farma6
Indonesia University5
Fakultas Kedokteran Universitas Indonesia4
Dexa Medica Group2
National Cardiovascular Center Harapan Kita Hospital Indonesia2
Universitas Padjadjaran2
Universitas Sriwijaya2
Australian National University1
Bristol-Myers Squibb1
Dr Cipto Mangunkusumo General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-192
Agnosia1
Breast Neoplasms1
Carcinoma, Transitional Cell1
Condylomata Acuminata1
Constipation1
Diabetes Mellitus, Type 21
Endometriosis1
Erythema1
Heat Stress Disorders1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.